“On a little speck of ice at the...end of the universe known as Kerenza IV…” an illegal mining colony is struggling to survive an invasion. “Obsidio” is the third book in the Illuminae Files trilogy ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add articles to your saved list and come back to them any time. Goodbyes are never easy, but after three books, four years, 1904 pages, and an even higher body count, Amie Kaufman and Jay Kristoff ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall. An ...

Boston Scientific's latest tuck-in acquisition could prove to be quite a "gem." The Marlborough, MA-based company announced the acquisition of Obsidio, a privately-held startup that has developed the ...

Boston Scientific announced on August 15, 2022, that it acquired Obsidio, Inc. for an undisclosed fee. Obsidio has technology called the Gel Embolic Material (GEM™), which is used in minimally ...

True to the Latin definition of its name, Obsidio is developing hydrogel technology that can create a blockade in the blood vessels to slow or stop the flow of blood to a tumor or other abnormality.

(RTTNews) - Medical technology company Boston Scientific Corp. (BSX) announced Monday the acquisition of privately-held company Obsidio, Inc. that has developed the Gel Embolic Material (GEM) ...

Boston Scientific Corporation BSX recently announced the acquisition of Obsidio, Inc. This privately-held company is the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.